Final analysis of European patients from the Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) study: Baseline characteristics and staging systems.
2014
4088 Background: The global, prospective, non-interventional GIDEON study recruiting >3,000 patients with unresectable hepatocellular carcinoma treated with sorafenib is complete. We report the fin...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI